Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics

被引:12
|
作者
de Haard, HJW
Kazemier, B
Koolen, MJM
Nijholt, LJ
Meloen, RH
van Gemen, B
Hoogenboom, HR
Arends, JW
机构
[1] Organon Teknika, Biosci Res Unit, Boxtel, Netherlands
[2] DLO, Inst Anim Sci & Hlth, ID, Dept Mol Recognit, Lelystad, Netherlands
[3] Maastricht Univ, Maastricht, Netherlands
[4] Univ Hosp, Dept Pathol, CESAME, Maastricht, Netherlands
关键词
D O I
10.1128/CDLI.5.5.636-644.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
By application of combinatorial library technology, we generated the first recombinant antibody fragments directed against the major capsid protein p24 of human immunodeficiency virus type 1 (HIV-1). A library of single-chain Fv fragments (scFvs) was constructed by using the antibody variable-region (V) genes of B cells derived from the spleen of a viral lysate-immunized mouse. Antibodies were selected by panning or by enrichment with biotinylated antigen, yielding four different families of antibody fragments. The different types of scFvs were characterized by affinity measurements, by antigen recognition on Western blots, and by pepscan analysis. The epitope of one of the scFvs is located near the residues involved in CypA binding, thereby making it an attractive candidate for therapeutic applications. Comparison of the V gene sequence of this scFV with that of a previously described monoclonal antibody reactive against this immunodominant epitope revealed the usage of the identical combination of V-H and V-kappa regions. Thus, this is one of the rare examples in which the original combination in a library-derived antibody fragment was retrieved. After appropriate affinity and format improvements, the best of our recombinant scFvs may form the basis for a sensitive p24 assay as a measure of viral load. In addition, anti-p24 scFvs could be expressed as intracellular antibodies (intrabodies) to aid in the treatment of HIV infections.
引用
收藏
页码:636 / 644
页数:9
相关论文
共 50 条
  • [21] Expression in E. coli and purification of Human Immunodeficiency Virus type 1 major core protein, p24
    Ehrlich, L.S.
    Krauesslich, H.-G.
    Wimmer, E.
    Carter, C.A.
    1990, (616)
  • [22] RECOMBINANT HUMAN FAB FRAGMENTS NEUTRALIZE HUMAN TYPE-1 IMMUNODEFICIENCY VIRUS INVITRO
    BARBAS, CF
    BJORLING, E
    CHIODI, F
    DUNLOP, N
    CABABA, D
    JONES, TM
    ZEBEDEE, SL
    PERSSON, MAA
    NARA, PL
    NORRBY, E
    BURTON, DR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) : 9339 - 9343
  • [23] HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection
    Coleman, JK
    Pu, RY
    Martin, M
    Sato, E
    Yamamoto, JK
    AIDS, 2005, 19 (14) : 1457 - 1466
  • [24] Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay
    Gürtler, L
    Mühlbacher, A
    Michl, U
    Hofmann, H
    Paggi, GG
    Bossi, V
    Thorstensson, R
    Villaescusa, RG
    Eiras, A
    Hernandez, JM
    Melchior, W
    Donie, F
    Weber, B
    JOURNAL OF VIROLOGICAL METHODS, 1998, 75 (01) : 27 - 38
  • [25] MOLECULAR VALIDATION OF PUTATIVE ANTIMICROBIAL PEPTIDES FOR IMPROVED HUMAN IMMUNODEFICIENCY VIRUS DIAGNOSTICS VIA HIV PROTEIN P24
    Williams, M. E.
    Tincho, M.
    Meyer, M.
    Pretorius, A.
    SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A211 - A212
  • [26] Characterization of one monoclonal antibody against feline immunodeficiency virus p24 and its application to antigen capture ELISA
    Kashiwase, H
    Ishimura, M
    Ishikawa, Y
    Nishigaki, T
    JOURNAL OF VIROLOGICAL METHODS, 1997, 68 (02) : 183 - 192
  • [27] Human immunodeficiency virus p24 antigen testing in cornea donors.
    Chung, CW
    Rapuano, CJ
    Lytle, RE
    Quirk, JT
    Laibson, PR
    Cohen, EJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S446 - S446
  • [28] Immunization with recombinant p17/p24:Ty virus-like particles in human immunodeficiency virus-infected persons
    Veenstra, J
    Williams, TG
    Colebunders, R
    Dorrell, L
    Tchamouroff, SE
    Patou, G
    Lange, JMA
    Weller, IVD
    Goeman, J
    Uthayakumar, S
    Gow, IR
    Weber, JN
    Coutinho, RA
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 862 - 866
  • [29] Evaluation of a recombinant p24 antigen for the detection of Feline Immunodeficiency Virus-specific antibodies
    Mazur, Carlos
    Reis, Jenner K. P.
    Leite, Romulo C.
    Danelli, Maria das Gracas M.
    Hagiwara, Mitika K.
    de Goes, Ana Carolina M. A.
    Medeiros, Marcos A.
    PESQUISA VETERINARIA BRASILEIRA, 2010, 30 (10): : 877 - 880
  • [30] MONITORING HUMAN IMMUNODEFICIENCY VIRUS TYPE-1-INFECTED PATIENTS BY RATIO OF ANTIBODIES TO GP41 AND P24
    SCHMIDT, G
    AMIRAIAN, K
    FREY, H
    WETHERS, J
    STEVENS, RW
    BERNS, DS
    JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (05) : 843 - 848